Keurig Dr Pepper

Keurig Dr Pepper launches €31.85/share all-cash bid for JDE Peet's. The $18B deal creates world's #1 pure-play coffee company, to be followed by spin-off.

Keurig Dr Pepper Launches $18 Billion Tender Offer for JDE Peet's, Creating World's Largest Pure-Play Coffee Company

Walmart

India Supreme Court rules Tiger Global's $1.6B Flipkart sale to Walmart is taxable, upending offshore treaty structures used by global PE/VC for decades.

India's Supreme Court Rules Tiger Global Must Pay Tax on $1.6B Flipkart Exit—A Watershed Moment for Foreign Investors

Kaiser Permanente pays $556M in largest Medicare Advantage fraud settlement ever. DOJ alleges decade-long scheme added 500,000 fake diagnoses.

Kaiser Permanente Pays Record $556 Million in Largest-Ever Medicare Advantage Fraud Settlement

ASML HOLDING

TAIWAN SEMICONDUCTOR MANUFACTURING CO

NVIDIA

INTEL

ASML crosses $500B market cap, joining LVMH and Novo Nordisk as only European companies to reach the milestone. TSMC's $56B capex drives the surge.

ASML Joins $500 Billion Club as Third European Company Ever

Talen Energy

Vistra

Constellation Energy

NRG ENERGY

Talen Energy pays $3.45B for 2.6 GW of gas plants, betting on data center power demand. Deal implies 6.6x EBITDA with 15%+ annual FCF accretion.

Talen Energy Bets $3.45 Billion on AI Power Demand With PJM Gas Plant Acquisition

ELI LILLY &

NOVO NORDISK A S

Sanofi

Disc Medicine

FDA extends Eli Lilly's orforglipron review to April 10, wiping $35B from market cap as Novo Nordisk's oral Wegovy gains three-month head start.

News

Today

Keurig Dr Pepper Launches $18 Billion Tender Offer for JDE Peet's, Creating World's Largest Pure-Play Coffee Company

India's Supreme Court Rules Tiger Global Must Pay Tax on $1.6B Flipkart Exit—A Watershed Moment for Foreign Investors

Kaiser Permanente Pays Record $556 Million in Largest-Ever Medicare Advantage Fraud Settlement

ASML Joins $500 Billion Club as Third European Company Ever

Talen Energy Bets $3.45 Billion on AI Power Demand With PJM Gas Plant Acquisition

Lilly Stock Drops 4% as FDA Delays Obesity Pill, Handing Novo Crucial Head Start